Liquid biopsy assay panel for detecting epidermal growth factor receptor (EGFR) mutations in lung cancer patients. Utilizes mdPCR technology for high-sensitivity screening and mutation identification from blood samples.
Manufactured by
Hsinchu City, Taiwan
LifeOS Genomics Corporation is an innovative biotechnology company based in Hsinchu Science Park, Taiwan. LifeOS Genomics is dedicated to the development and commercialization of cutting-edge automated genetic testing instruments and assay reagents that enable routine genetic testing in hospitals and distributed test laboratories. The company is ISO13485:2016 certified and in full compliance with FDA Quality System Regulation (QSR). Bridging the Gap Between PCR and NGS QLoci md1000 Dx Analyzer is based on LifeOS Genomics proprietary Multiplex Digital PCR (mdPCR) technology. It brings about a significant advancement in genetic testing that bridges the gap between research and clinical utility, by providing a platform that can be used for seamlessly translating biomarkers from research into clinical practice. The QLoci md1000 Dx Analyzer provides unique features that open up new possibilities for clinical molecular testing market. Addressing Unmet Needs in Liquid Biopsy The QLoci md1000 Dx Analyzer fills a critical gap between traditional PCR and Next-Generation Sequencing (NGS) by offering unmatched capabilities of addressing unmet needs in liquid biopsy in research and clinical diagnosis. With its unmatched sensitivity and accuracy for clinically relevant biomarkers , our fully automated sample-to-report workflow simplifies the decision-making of medical professionals and researchers in their daily work.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
TRUPCR Europe Ltd
United Kingdom · 9 relevant products
Biopsense Oy
Finland · 2 relevant products
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 4 relevant products
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 2 relevant products
YouSeq
United Kingdom · 2 relevant products
Burning Rock Dx Co. Ltd.
China · 8 relevant products
Genes 2Me Private Ltd
India · 2 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 4 relevant products
Fujirebio Diagnostics,Inc.
China · 1 relevant product
42 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 111 closest product alternatives
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for detecting mutations associated with lung cancer. This panel identifies genetic alterations relevant to lung cancer diagnosis and treatment planning.
Biopsense Oy · Finland
Blood test panel for detecting and characterizing genetic and epigenetic mutations in circulating tumor DNA. Helps determine cancer origin, measure tumor burden, and identify new mutations during targeted therapy treatment.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Comprehensive genetic screening kit for lung cancer biomarkers and mutations. Enables early detection and treatment planning for pulmonary malignancies.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Diagnostic kit for detecting relevant mutations in colorectal cancer tissue samples. Identifies mutations affecting prognosis and treatment selection.
YouSeq · United Kingdom
A multiplex molecular panel utilizing qPCR and NGS technology for detection of breast cancer-associated genetic markers and mutations. Supports diagnostic confirmation and prognostic assessment for breast cancer management.
Burning Rock Dx Co. Ltd. · China
Focused testing panel targeting common cancer-associated mutations for rapid diagnostic confirmation. Provides quick results for urgent treatment decisions.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit designed to detect mutations associated with colorectal cancer. This panel enables identification of genetic alterations relevant to colorectal cancer diagnosis and management.
Genes 2Me Private Ltd · India
Genomic sequencing panel for cancer-related mutation and biomarker detection. Supports precision oncology treatment planning and selection.
Burning Rock Dx Co. Ltd. · China
Next-generation sequencing panel for comprehensive cancer genomic profiling. Identifies mutations, copy number variations, and other genetic alterations to guide personalized treatment strategies.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cancer screening and early detection. Part of the comprehensive oncology testing portfolio covering multiple cancer types.
BioChain (Beijing) Science & Technology. Inc. · China
Next-generation sequencing-based multiplex cancer screening panel for simultaneous detection of multiple cancer types. This advanced molecular diagnostic test enables comprehensive cancer risk stratification from single blood samples. The product is in development as part of the company's precision oncology pipeline.
Fujirebio Diagnostics,Inc. · China
In vitro diagnostic test panel for detection of multiple tumor markers with simplified experimental workflow and reliable accuracy. The assay provides stable results suitable for cancer screening and monitoring.
99 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products